Stevens will assume full responsibility for global merger and acquisitions and specialty business strategy, Lupin said in a filing to the BSE.
Prior to joining Lupin, Stevens was with Aptalis pharma as the Chief Corporate Development Officer responsible for M&A, strategy and global business development.